Evidence map›Paper›PMID 31428439›Full record

ArticleJournal of pharmaceutical health care and sciences2019

Evaluating the effect of aromatherapy on a stress marker in healthy subjects.

Chiaki Takagi, Saori Nakagawa, Naoto Hirata, Shin Ohta, Sadahiko Shimoeda

Open access · goldAbstract read
In one paragraph

Article in Journal of pharmaceutical health care and sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Chiaki Takagi1Tokyo University of Pharmacy and Life Sciences, 1432-1, Horinouchi, Hachiohji Tokyo, Japan.
Saori Nakagawa2Niigata University of Pharmacy and Applied Life Sciences, 265-1, Higashijima, Akiha, Niigata, Japan.
Naoto Hirata1Tokyo University of Pharmacy and Life Sciences, 1432-1, Horinouchi, Hachiohji Tokyo, Japan.
Shin Ohta1Tokyo University of Pharmacy and Life Sciences, 1432-1, Horinouchi, Hachiohji Tokyo, Japan.
Sadahiko Shimoeda1Tokyo University of Pharmacy and Life Sciences, 1432-1, Horinouchi, Hachiohji Tokyo, Japan.
Tokyo University of Pharmacy and Life Sciences · JPNiigata University of Pharmacy and Applied Life Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background/purposeChemotherapy is important for cancer treatment, but patients' physical and mental stress may lead to unfavorable pain control, an increase in the risk of relapse, and a reduction in the quality of life (QOL). Recently, aromatherapy has been performed in addition to palliative care in many countries, such as Japan and the United States, but scientific evidence remains insufficient. To investigate the usefulness of aromatherapy as complementary and alternative medicine, we evaluated its influence on the immune and autonomic nervous systems.

methodsWe instructed healthy volunteers to inhale aroma oil at bedtime for 6 weeks, and measured changes in the salivary level of secretory immunoglobulin A (s-IgA). Furthermore, blood was collected in addition to saliva in some healthy volunteers, and the blood level of noradrenaline (NA) was measured to examine its relationship to changes in the salivary s-IgA level.

resultsAromatherapy with lavender and grapefruit oils significantly increased the salivary s-IgA level: lavender oil increased 3.5-fold (

conclusionThe results showed that aromatherapy with lavender and grapefruit oils reduced stress by acting on the immune and autonomic nervous systems in healthy volunteers. In the future, its clinical usefulness must be investigated through similar examination in patients in whom the stress level may be high.

Indexed as

AromatherapyComplementary and alternative medicineNoradrenalineSecretory immunoglobulin AStress

Identifiers

PMID31428439
PMCPMC6693249
OpenAlexW2968403906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.